Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Meghana Aruru, PhD, MBA, BSPharm
Assistant Professor,
Roosevelt University College of Pharmacy,
Schaumburg, IL
Assistant Professor, Roosevelt University College of Pharmacy, Schaumburg, IL
Authored Items
Development of a Medicare Beneficiary Comprehension Test: Assessing Medicare Part D Beneficiaries’ Comprehension of Their Benefits
Meghana Aruru, PhD, MBA, BSPharm
,
Joseph R. Antos, PhD
,
J. Warren Salmon, PhD
September/October 2013, Vol 6, No 8
in
Practice Management
Assessment of Medicare Part D Communications to Beneficiaries
Jack E. Fincham, PhD, RPh
,
Meghana Aruru, PhD, MBA, BSPharm
,
J. Warren Salmon, PhD
September/October 2010, Vol 3, No 5
in
Practice Management
Last modified: October 24, 2013